NON-MELANOMA SKIN CANCER
Clinical trials for NON-MELANOMA SKIN CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-MELANOMA SKIN CANCER trials appear
Sign up with your email to follow new studies for NON-MELANOMA SKIN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Electric shocks + chemo: new hope for inoperable tumors?
Disease control Recruiting nowThis study tests a treatment called electrochemotherapy for people with tumors in organs like the liver or pancreas that cannot be removed by surgery. The treatment uses short electrical pulses to help chemotherapy drugs enter cancer cells more effectively. The goal is to shrink …
Matched conditions: NON-MELANOMA SKIN CANCER
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Poop pills? stool transplants may ease immunotherapy side effects
Disease control Recruiting nowThis early-stage trial tests whether a stool transplant (FMT) can help cancer patients who develop severe diarrhea or colon inflammation from immune-checkpoint inhibitor drugs. About 40 patients with various cancers will receive the transplant via colonoscopy. The main goal is to…
Matched conditions: NON-MELANOMA SKIN CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Immune cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called EBNK-001, made from donor immune cells (natural killer cells), in people with advanced solid tumors that have not responded to standard therapies. Participants receive the cells after chemotherapy to prepare the body, along with low-dose in…
Matched conditions: NON-MELANOMA SKIN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Simple cream may shield transplant patients from skin cancer
Prevention Recruiting nowThis study tests whether a daily application of 5% niacinamide cream can prevent skin cancer in organ transplant recipients, who are at high risk due to long-term immune-suppressing drugs. Twenty adult transplant recipients with a history of precancerous skin spots and at least o…
Matched conditions: NON-MELANOMA SKIN CANCER
Phase: EARLY_PHASE1 • Sponsor: Marissa Lobl • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC